Spotlight

UCL cancer immunotherapy company, Autolus, launches with £30m investment

A new UCL spin-out company – Autolus – is being launched today to develop and commercialise a new generation of engineered T-cell therapies for haematological and solid tumours, with the backing of £30m in investment from healthcare investment company Syncona.

Find out more



follow us on twitter


Entrepreneurial Finance - Short Courses in Small Company Management

Publication date: Sep 28, 2011 09:36 AM

Start: Oct 27, 2011 09:00 AM
End: Nov 02, 2011 05:00 PM

[image reference is broken]

This 5-day course is designed for anybody who is intending or even just interested in becoming an entrepreneur by setting up their own business. It would also be of value to individuals who are interested in becoming investors in another group’s entrepreneurial endeavour.

There is no requirement for any particular business experience as the initial modules in the programme include a review of the potentially applicable business environment.

Find out more >>